Chaga
Inonotus obliquus · Birch-Tree Fungus
Evidence grade 1 of 5, Untested. Read how the Atlas grades evidence.
The honest grade is 1, anecdotal and traditional. Chaga carries a deep multi-cultural folk inheritance and a large laboratory literature, but the human record is close to empty. The 2023 Fungal Biology review by Lu and colleagues surveys the field and rests almost entirely on in-vitro and animal work, noting the mechanisms behind most claimed effects are still not well understood and that no named randomized controlled trial supports any use. Small human reports circulate (for example an 8-week natural-killer-cell observation), but nothing of trial quality confirms an immune or antioxidant benefit in people. Against that thin benefit sits a real documented harm: peer-reviewed case reports of calcium-oxalate nephropathy in heavy users, including progression to end-stage renal disease. Any number above 1 would overstate what has actually been shown in humans.
- FDA
- Legal supplement (DSHEA)
- WADA
- Not prohibited
Reference only. Not medical advice.
What can go wrong
High-oxalate; peer-reviewed case reports tie heavy or prolonged use to calcium-oxalate kidney injury, including one progression to end-stage renal disease, so it is best avoided by anyone with kidney disease, kidney stones, or gout.
Chaga is a slow-growing fungus that parasitizes birch trees across the cold northern forests of Siberia, Scandinavia, and northern North America, prized in folk medicine long before any laboratory looked at it. Its dark, cracked conk is rich in melanin and polyphenols, which is why it posts among the highest antioxidant readings of any studied mushroom in the test tube. That laboratory profile has not translated into human evidence: there are no meaningful clinical trials, and nearly everything known about benefit comes from cell and animal studies. What is well documented is a harm. Chaga is extraordinarily high in oxalate, and heavy daily use has been tied in peer-reviewed case reports to calcium-oxalate kidney injury, in at least one patient progressing to end-stage renal disease.
The highest-ORAC mushroom, with a real oxalate-related kidney concern.
What people take it for
These are the reasons people give for taking it. They are not effects it has been shown to have.
How it is supposed to work
Chaga contains beta-glucans (immune-modulating), melanin (highest content of any fungus), triterpenes (betulinic acid and inotodiol, from the birch tree substrate), and an unusually high oxalate concentration. The mechanism profile overlaps reishi and turkey tail for immune modulation; the antioxidant content (ORAC value) is the highest measured of any medicinal mushroom. The oxalate concentration is the safety-relevant distinguishing feature.
How it is taken
Chaga is typically dosed at 1-3g daily of wild-harvested chaga powder, or 500-1000mg 1-2 times daily of dual-extract concentrate (hot water + ethanol extraction). Take consistently, adaptogenic and antioxidant effects develop over weeks to months of consistent supplementation rather than acute pharmacological effect. The substantial form-factor preference is wild-harvested conk (from birch trees) over cultivated mycelium (substantially different chemical profile lacking substantial betulinic acid content from birch substrate). Dual extraction provides broadest pharmacological coverage (hot water for beta-glucans + ethanol for triterpenes including betulinic acid and inotodiol). Take with or without food, absorption is reasonable either way. Traditional decoction framework involves simmering chaga in water for 1-4 hours to extract water-soluble compounds; provides modest pharmacological coverage relative to dual extract. The substantial oxalate content is the foundational safety consideration, substantially the highest oxalate concentration of any commercially marketed medicinal mushroom. Users with calcium oxalate kidney stone history should substantially avoid chaga supplementation; substantial hydration matters for general supplementation contexts. The substantial anticoagulant effects through various mechanisms create substantial warfarin and DOAC interaction concern; anticoagulation specialist coordination essential. Pregnancy and lactation: generally avoid given limited safety data, substantial anticoagulant effects, and substantial oxalate content. Pediatric use: substantially avoid without specialist coordination given limited safety data and substantial oxalate burden. Renal disease: substantially avoid given substantial oxalate burden; nephrology coordination essential. Cycling consideration may matter for sustained use given substantial oxalate burden, some practitioners recommend 8-12 weeks on, 2-4 weeks off though substantial evidence base is limited. Sustainable sourcing matters substantially, wild chaga harvest must allow tree recovery; cultivated mycelium alternatives substantially less ecologically impactful but pharmacologically different.
- Standard daily dose
- 1-3g wild-harvested chaga powder daily
- Dual-extract dose
- 500-1000mg 1-2x daily
- Beta-glucan content
- 8-30% standardized
- Form preference
- Wild conk > cultivated mycelium
- Extraction preference
- Dual extract (hot water + ethanol) > single extract > whole powder
- Oxalate burden
- Highest of any commercial medicinal mushroom
- Kidney stone history
- AVOID; nephrology coordination
- Anticoagulant users
- AVOID without specialist coordination
Which form to buy
Not all preparations of the same ingredient are the same thing, and the trials were run on particular ones.
Wild-Harvested Chaga Dual Extract (Hot Water + Ethanol)
Wild-harvested chaga (Inonotus obliquus) from birch trees in northern boreal forests (Russia, Finland, Canada, Northeast US, Siberia) provides the foundational pharmacological framework. Dual extraction (hot water for beta-glucans + ethanol for triterpenes and betulinic acid) yields broadest pharmacological coverage. Standardized to 8-30% beta-glucans and triterpene content. Reputable wild-harvested sources (Annanda Chaga, Sayan Health, Real Mushrooms, Nordic Naturals chaga) preferred for therapeutic positioning.
Sustainably-Harvested Chaga Conk Pieces
Whole chaga conk pieces (the sclerotium that grows on living birch trees) provided sustainably with attention to harvest timing (proper harvest does not kill the host tree if practiced correctly). Substantially fewer commercial products than powder extracts; reasonable framework for traditional decoction preparation.
Cultivated Chaga (Liquid Culture / Mycelium)
Cultivated chaga mycelium produced through liquid fermentation, substantially less expensive but substantially different chemical profile than wild conk (lacks substantial betulinic acid content derived from birch tree substrate). Reasonable budget option; substantially inferior to wild conk for therapeutic positioning.
Chaga Tea (Whole Powder Decoction)
Traditional preparation, simmer chaga powder or conk pieces in water for 1-4 hours to extract beta-glucans and water-soluble compounds. Modest pharmacological coverage (water-soluble fraction only; lacks ethanol-soluble triterpenes). Reasonable cultural framework; substantially less therapeutic than dual extract.
Chaga Capsules / Tablets
Standardized chaga extract in capsule or tablet form. Convenient supplementation framework; verify dual extraction and standardization details.
Chaga in Functional Mushroom Coffee/Tea Blends
Mushroom coffee products (Four Sigmatic and similar brands) often include modest chaga content alongside other functional mushrooms. Reasonable consumer entry point; modest dosing relative to dedicated standalone supplementation.
Multi-Ingredient Functional Mushroom Stacks
Multi-mushroom blends (Host Defense MyCommunity, Real Mushrooms 5 Defenders, Om Mushrooms Master Blend, others) provide comprehensive functional mushroom support including chaga alongside reishi, lion's mane, cordyceps, turkey tail, others. Reasonable comprehensive supplementation; modest individual mushroom doses.
Generic Chaga Without Source/Extraction Specification
Many products labeled "chaga" without specifying wild vs cultivated, conk vs mycelium, extraction method, or active compound content. Substantial commercial opacity; verify specifications before purchase.
Who it works for, and who it does not
Adults seeking antioxidant and immune support supplementation
Chaga has substantially the highest ORAC (Oxygen Radical Absorbance Capacity) of any food or supplement measured, substantial antioxidant capacity. Beta-glucan content provides modest immune modulation evidence. Reasonable adjunctive supplementation for antioxidant and immune contexts; effect sizes modest.
Adults seeking traditional Russian / Siberian medicinal framework
Substantial traditional use in Russian, Siberian, and Northern European folk medicine for centuries. Aleksandr Solzhenitsyn referenced chaga in "Cancer Ward" (1968) for its traditional use in Russian cancer wards. Reasonable traditional adaptogenic framework.
Adults seeking antioxidant support (chronic disease prevention contexts)
Substantial preclinical antioxidant evidence; limited translation to clinical outcomes in well-designed RCTs. Reasonable adjunctive supplementation; not substitute for established preventive medicine.
Kidney stone history
Chaga has substantially the highest oxalate concentration of any commercially marketed medicinal mushroom, substantial oxalate burden may exacerbate kidney stone formation in susceptible users. Substantial nephrology coordination essential; substantially avoid in users with calcium oxalate kidney stone history.
Anticoagulant users
Chaga has substantial anticoagulant and antiplatelet effects through various mechanisms. Substantial warfarin and DOAC interaction concern; specialist coordination essential.
Diabetes and glycemic management
Modest hypoglycemic activity; theoretical hypoglycemic medication interaction. Monitor glycemic markers during initial supplementation; coordinate with diabetes management.
Autoimmune disease
Beta-glucan immune modulation may theoretically affect autoimmune disease progression. Coordinate with rheumatology or autoimmune specialists.
Pregnancy and lactation
Limited safety data; substantial anticoagulant effects and substantial oxalate content create substantial pregnancy contraindication. Generally avoid during pregnancy and lactation.
Pediatric use
Limited pediatric safety data; substantial oxalate content and anticoagulant effects create pediatric supplementation context. Pediatric specialist coordination essential.
Renal disease
Substantial oxalate content creates substantial renal burden; users with chronic kidney disease should generally avoid chaga supplementation. Nephrology coordination essential.
Taken with other things
Combinations people actually use. Evidence for one ingredient is not evidence for a pair.
Other Functional Mushrooms (Reishi, Lion's Mane, Cordyceps, Turkey Tail)
Reasonable combination for comprehensive functional mushroom supplementation; each mushroom provides distinct pharmacological profile. Multi-mushroom blends provide broader coverage at modest individual mushroom doses.
Antioxidant Supplementation (Vitamin C, Vitamin E, Polyphenols)
Substantial antioxidant capacity (highest ORAC of any commercial supplement) complements broader antioxidant supplementation framework. Reasonable comprehensive antioxidant positioning.
Coffee and Caffeine
Modest chaga integration in mushroom coffee products (Four Sigmatic and others). Reasonable consumer convenience framework.
Anticoagulants (Warfarin, DOACs, Antiplatelets)
Substantial anticoagulant effects through chaga's polysaccharide and other mechanisms create substantial warfarin INR and DOAC interaction. Substantially avoid combination without specialist anticoagulation coordination.
Hypoglycemic Medications
Modest hypoglycemic activity; theoretical interaction with diabetes medications. Monitor glycemic markers during initial supplementation.
Immunosuppressants
Beta-glucan immune modulation may interact with immunosuppressant therapy. Specialist coordination essential.
Calcium Supplementation
Substantial oxalate content forms calcium oxalate crystals; coordinate calcium and chaga timing if both supplemented. Substantial kidney stone risk consideration.
Pregnancy and Lactation
Substantial anticoagulant effects, oxalate burden, and limited safety data create substantial pregnancy contraindication.
Renal Disease
Substantial oxalate burden creates substantial renal stress; avoid in chronic kidney disease.
Kidney Stone History
Substantial oxalate content substantially exacerbates calcium oxalate stone formation. Avoid in stone-prone users.
What to look for on the label
Look for: wild-harvested conk source from birch trees in northern boreal forests (Russia, Finland, Canada, Northeast US, Siberia); sustainable harvest practices that allow tree recovery; explicit beta-glucan content (8-30% standardized); dual extraction framework (hot water + ethanol) for therapeutic positioning; reputable manufacturer with third-party testing disclosure (heavy metals, contamination, identity verification); appropriate dose for intended application (1-3g daily). Avoid: cultivated mycelium products labeled as chaga (substantially different chemical profile); products without source verification (wild vs cultivated, conk vs mycelium); products without standardized beta-glucan content disclosure; products without sustainability disclosure; use in users with kidney stone history, renal disease, or warfarin therapy without specialist coordination.
Safety in detail
- Oxalate content is among the highest in any dietary source, substantially higher than spinach or rhubarb per gram.
- Documented case reports of severe and fatal oxalate nephropathy in heavy chaga users. Caution with kidney disease, kidney stone history, and any predisposition to oxalate-related disease.
- Theoretical antiplatelet activity; coordinate with anticoagulant prescribing.
- Real interactions with diabetes medications (hypoglycemic potential).
- Wild-harvested chaga from birch trees can be sustainable when harvested responsibly; demand-driven over-harvesting in some regions has raised concerns.
What people get wrong
Often saidChaga prevents or treats cancer.
ActuallyThe literary prominence (Solzhenitsyn) outpaced the clinical evidence. Modern human trials are preliminary; routine use as cancer prevention is not evidence-supported.
Often saidChaga is safe because it's natural.
ActuallyThe oxalate content is among the highest in any food source. Case reports of fatal kidney injury exist.
Often saidWild and cultivated chaga are equivalent.
ActuallyMost commercial product is wild-harvested; meaningful cultivation has been difficult. Source quality and sustainability vary.
Who profits, and who pushes back
Kikuchi case-report authors
The oxalate content of chaga is genuinely high and the nephropathy risk is real. Patients with any kidney function impairment or oxalate-stone history should avoid this supplement. Consumer warnings would be appropriate.
Christopher Hobbs
Independent traditional-use and modern-mechanism reference voice.
Paul Stamets
Sells this. Has a commercial interest in a product sold as this compound, as of July 2026.
Brand owner. Quality information; conflicted on the supplement-category question.
Indigenous knowledge keepers
Original cultural inheritors of North American chaga traditions. Modern wellness commercialization carries cultural-appropriation questions worth respecting.
How we got here
Chaga has multi-cultural traditional inheritance: Russian and Siberian peasant medicine (since at least the 16th century), Cree and Ojibwe Indigenous North American use, and Finnish-Karelian folk medicine. Solzhenitsyn's 1968 novel Cancer Ward (Раковый корпус) included a substantial passage about a Russian peasant medical practitioner using chaga extract for cancer, driving substantial post-Soviet-era Western interest. The literary prominence has somewhat outpaced the clinical evidence.
- ~1500sFirst Russian and Siberian medical documentation
- 1860sRussian medical investigation begins
- 1968Solzhenitsyn's Cancer Ward popularizes Western interest
- 1990sAntioxidant research characterizes chaga's ORAC profile
- 2014Kikuchi fatal oxalate nephropathy case report
- 2020sFunctional mushroom mainstreaming, oxalate concerns emerging
What we do not know
- Whether the immune-modulatory and antioxidant evidence in vitro translates to clinically meaningful human outcomes.
- Optimal extraction method to balance bioactive capture against oxalate concentration (hot water extraction captures both; oxalate concentration in extracts is typically high).
- Whether case reports of nephropathy reflect rare idiosyncratic susceptibility or generalizable risk above some chronic-intake threshold.
- Sustainability of wild harvesting given growing global demand.
Legal status
Universally available as a dietary supplement. Most products are wild-harvested from northern hemisphere birch forests (Russia, Canada, Finland, Alaska, the Adirondacks). No regulatory restrictions, but the oxalate-safety concern has not yet led to consumer warnings on labels.
Status current as of July 2026. Regulatory positions change, sometimes quickly.
The market for this
What follows describes how this is bought and sold. It is not a buying guide and it is not an endorsement of any seller.
Wild-harvested chaga conks from birch trees, hot-water extracted, is the traditional and most-studied form. Cultivated chaga is more difficult than other medicinal mushrooms; most commercial product is genuinely wild-harvested. Sustainability and harvesting practice matter, irresponsible harvesting damages host trees and depletes regional populations.
At a glance
- Active fractions
- Beta-glucans, betulinic acid, inotodiol, melanin
- Typical dose
- 1-3g/day extract
- Oxalate concern
- Among highest in dietary sources
- Traditional regions
- Russia, Siberia, North America, Finland
- Solzhenitsyn reference
- Cancer Ward (1968)
- Sourcing
- Wild-harvested birch substrate
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Chaga. A short entry is not a safe entry.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
Sources
69-year-old man taking 10-15 g chaga plus 500 mg vitamin C daily for 3 months developed acute oxalate nephropathy with calcium-oxalate tubular crystals, needed hemodialysis and steroids, recovered in one month
Medicine (Baltimore), Chaga mushroom-induced oxalate nephropathy manifesting as nephrotic syndrome
Long-term chaga ingestion associated with development of end-stage renal disease (Korean case report)
High-dose chaga reproduces dose-dependent kidney injury in a rat model, supporting oxalate as the causal agent
Human clinical evidence for chaga is essentially absent; the field rests on in-vitro and animal work; named constituents include inotodiol, betulinic acid, ergosterol peroxide, trametenolic acid, polysaccharides, melanin, and polyphenols; mechanisms Nrf2, NF-kappa-B, AMPK, xanthine oxidase
Chaga folk history: Khanty and other Siberian peoples, Russian/Polish/Baltic 16th-century use, name from Komi-Permyak; Cree poashkan and moxibustion, Chipewyan and Ojibwe tea and skin use
Chaga mushroom: a super-fungus with countless facets and untapped potential (review, PMC)
Chaga review notes high antioxidant activity from melanin and phenolics but that human clinical trials are sparse and efficacy remains unestablished; folk-to-clinical framing
Chaga is an unauthorised novel food in the EU; the 25 March 2022 Commission decision terminated the authorisation procedure; permitted only in limited extract forms within food supplements
European Commission Food Safety, Novel food decisions terminating the procedure
Chaga in the EU is considered a novel food usable only broken or as aqueous/ethanol extract in food supplements; regulatory summary for functional mushrooms
Functional Mushrooms EU, Novel Food and Functional Mushrooms
Physician-facing note on chaga oxalate risk and the need to monitor intake and kidney status
Ubie Health Doctor's Note, Chaga mushroom powder oxalate risks
The studies that matter
Glamoclija Inonotus polyphenol characterization2015
Established the unusually high antioxidant content and major bioactive fractions.
Solzhenitsyn Cancer Ward1968
Literary, not clinical: the Soviet novelist's prominent description of Russian peasant chaga use for cancer drove substantial Western interest. The clinical evidence has not subsequently matched the literary prominence.
Kikuchi case report fatal oxalate nephropathy2014
Documented fatal kidney injury in a heavy chaga user, a reference case in the oxalate-safety literature.
Glamočlija immune-modulation trialsMultiple
In vitro and animal studies of beta-glucan immune effects; human outcome trial evidence is preliminary.